Martin Shkreli suddenly changes his tune on Clinton threat; Genenta adds $8M for gene therapy R&D – Endpoints News
|
Martin Shkreli suddenly changes his tune on Clinton threat; Genenta adds $8M for gene therapy R&D
Endpoints News Milan-based Genenta Science raised an $8 million B round for its work in hematopoietic stem cell gene therapy for tumor treatment. The round was led by Italian, British, and Swiss private investors, family offices, and business angels, its Series A … |
